Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation

NACompletedINTERVENTIONAL
Enrollment

18,621

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
End Stage Renal Disease
Interventions
OTHER

Payment adjustment for home dialysis and transplant

The ETC model makes two types of payment adjustments for facilities and managing clinicians, an adjustment to the reimbursement rate for home dialysis, and a performance adjustment. The first adjustment, Home Dialysis Payment Adjustment (HDPA), raises the reimbursement rate for home dialysis for the first three years of the program; the amount of increase is 3% in 2021, and reduces to 2% in 2022, and 1% in 2023. The second adjustment, Performance Payment Adjustment (PPA), is an increase or decrease in the reimbursement rate based on the home dialysis rate and the transplant rate attributable to the participating facility or clinician.

Trial Locations (1)

02142

Massachusetts Institute of Technology, Cambridge

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

lead

Amy Finkelstein

OTHER

NCT05005572 - Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation | Biotech Hunter | Biotech Hunter